Hospital Mater Dei (MATD3) Q1 2026 earnings summary

Executive summary

• Achieved record net revenue of BRL 575 million in Q1 2026, up 15.1% year-over-year, with sequential growth from Q4 2025, despite seasonal headwinds.

• Adjusted EBITDA grew 35% year-over-year to BRL 130 million, with margin expanding by 3.3 percentage points to 22.6%.

• Net income rose 80% year-over-year to BRL 36 million, with a margin of 6.3%.

• Operational efficiency and record occupancy rates (84%) contributed to margin expansion and robust financial performance.

• Credit ratings were reaffirmed (Fitch AA+ (bra), Moody's AA+.br), reflecting strong cash generation and financial discipline.

Financial highlights

• Net revenue reached BRL 575 million, a 15.1% increase year-over-year.

• Average ticket per bed/patient rose 8.4% year-over-year to BRL 2.85–2.86 thousand, outpacing inflation.

• Adjusted EBITDA margin improved to 22.6%, up 3.3 percentage points year-over-year.

• Net income margin increased to 6.3%, with net profit up 79.8% year-over-year.

• Cost of services provided was 69.5–69.8% of net revenue, down 1.4 percentage points year-over-year.

Outlook and guidance

• Management projects continued positive cash generation, margin maintenance at higher levels, and gradual maturation of hospital assets.

• Focus remains on deleveraging, disciplined capital allocation, and potential for increased dividends and selective M&A.

• Plans to open new hospital beds in coming quarters, maintaining occupancy above 80%.